1)Borhani NO, Mercouri M, Buckalew VM, et al. Final outcome results of Multicenter Isradipine Diuretic Atheroscterosis Study (NIDAS); a randomized controlled trial. JAMA 1996; 276: 785-791.
2)Fruberg CD, Psaty BM, Meyer JV. Nifedipine dose-related increase in 16 mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-31.
3)Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction assoziated with antihypertensive drug therapies. JAMA 1995; 274: 620-25.
4)Opie LH, Messerli FH. Nifedipine and mortality grave defects in the dossier. Circulation 1995; 92: 1038-73.
5))Messerli FH. Case-control study, meta-analysis and bouillabaisse: putting the calcium antagonist scare into context. Ann Intern Med 1995; 123: 888-9.
12)Pahor M, Guralinik JM, Ferrucci L, et al. Risk of gastrointestinal hemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996; 347:1061-65.
13)Pahor M, Guralnik JM, FerrucciL, et al. Calcium-channel blockade and incidence of 18 cancer in aged populations. Lancet 1996; 348: 493-97.